Commitment to Health Strategies in Portugal: A Pathway Towards Sustainable Change

By João L. Carapinha

May 27, 2026

health strategies Portugal

In advancing health strategies in Portugal, the Ordem dos Farmacêuticos met with Adalberto Campos Fernandes to urge the country to move from promising ideas to concrete implementation of the Pacto Estratégico para a Saúde. Represented by Bastonário Helder Mota Filipe, Vice-President Dario Bastos Martins, and Secretary-General Ricardo Santos, the OF called for long-term stability in the health system that transcends political cycles while tackling immediate SNS pressures.

Five Pillars for Reform

The OF proposed five strategic pillars: reinforcing access and response capacity, securing interprofessional commitments with professional valorization, ensuring sustainability amid therapeutic innovation, advancing digital health with interoperability, and strengthening equity and proximity in care. These priorities reinforce the need for health strategies Portugal to deliver measurable results for citizens and pharmacists alike.

The meeting formed part of the President of the Republic’s initiative for a national health pact. The OF reaffirmed its readiness to contribute actively, balancing immediate SNS responsiveness with forward-looking planning that avoids postponing essential decisions.

Path to Sustainable Equity

By emphasizing sustainability, therapeutic innovation, and citizen-centered access, the OF’s input supports planning mechanisms that can improve resource allocation and system resilience while informing reimbursement frameworks that maintain innovation without compromising equity.

Reference url

Recent Posts

European Health Resilience
European Health Resilience: Strengthening Preparedness Amidst Geopolitical Challenges
EFPIA and Vaccines Europe endorse the European Commission’s Communication titled “Reinforcing Global Health Resilience Amidst Geopolitical Change,” published on 13 May, as a constructive advancement in bolstering European Health Resilience within a fragmented global environment. The statement hig...
MDR software regulations
Impact of MDR Software Regulations on Medical Device Innovation

By João L. Carapinha

May 26, 2026

MDR software regulations under the EU’s Medical Device Regulation (EU 2017/745) are creating heavy operational and financial pressures, according to a survey of 35 SaMD manufacturers listed in the EUDAMED database. Financial burdens hit 88.6 % of respondents at significant or severe levels, while...
GBA-PD therapy development
Key Milestone in GBA-PD Therapy Development Achieved with ACTIVATE Study Completion
Bial announced the completion of the treatment period in its Phase 2b ACTIVATE study evaluating BIA 28-6156 (pariceract) in patients with Parkinson’s disease (PD) who carry a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene, referred to as GBA-PD. The 78-week double-blind treatment pha...